Zivo Bioscience Warrants Alpha and Beta Analysis

ZIVOWDelisted Stock  USD 0.55  0.07  14.58%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zivo Bioscience Warrants. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zivo Bioscience over a specified time horizon. Remember, high Zivo Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zivo Bioscience's market risk premium analysis include:
Beta
(1.78)
Alpha
0.61
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Zivo Bioscience alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Zivo Bioscience did 0.61  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Zivo Bioscience Warrants stock's relative risk over its benchmark. Zivo Bioscience Warrants has a beta of 1.78  . As returns on the market increase, returns on owning Zivo Bioscience are expected to decrease by larger amounts. On the other hand, during market turmoil, Zivo Bioscience is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Zivo Bioscience Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zivo Bioscience market risk premium is the additional return an investor will receive from holding Zivo Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zivo Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zivo Bioscience's performance over market.
α0.61   β-1.78

Zivo Bioscience Fundamentals Vs Peers

Comparing Zivo Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Zivo Bioscience's direct or indirect competition across all of the common fundamentals between Zivo Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Zivo Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Zivo Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Zivo Bioscience to competition
FundamentalsZivo BiosciencePeer Average
Return On Equity-39.56-0.31
Return On Asset-1.65-0.14
Operating Margin(133.25) %(5.51) %
Number Of Shares Shorted5.63 K4.71 M
EBITDA(8.73 M)3.9 B
Net Income(8.75 M)570.98 M
Total Debt445.18 K5.32 B

Zivo Bioscience Opportunities

Zivo Bioscience Return and Market Media

The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Veru Q2 2023 Earnings Preview - Seeking Alpha
05/10/2023
2
ZIVO Bioscience, Inc. Stock Price Today, Quote News - Seeking Alpha
05/26/2023
3
Zivo Bioscience Inc. Announces Pricing of 4.0 Million Registered ... - Investing.com South Africa
06/30/2023

About Zivo Bioscience Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zivo or other delisted stocks. Alpha measures the amount that position in Zivo Bioscience Warrants has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zivo Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zivo Bioscience's short interest history, or implied volatility extrapolated from Zivo Bioscience options trading.

Build Portfolio with Zivo Bioscience

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.